학술논문
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
Document Type
Article
Author
Source
In The Lancet 27 May-2 June 2017 389(10084):2117-2127
Subject
Language
ISSN
0140-6736